CORONAVIRUS/TRUMP ADMIN/VACCINES: “Before Pfizer’s coronavirus vaccine was proved highly successful in clinical trials last month, the company offered the Trump administration the chance to lock in supplies beyond the 100 million doses the pharmaceutical maker agreed to sell the government as part of a $1.95 billion deal months ago.
But the administration, according to people familiar with the talks, never made the deal, a choice that now raises questions about whether the United States allowed other countries to take its place in line.”
-Sharon LaFraniere, Katie Thomas and Noah Weiland, “Trump administration officials passed when Pfizer offered months ago to sell the U.S. more vaccine doses.,” nytimes.com, Dec. 7, 2020